<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Evaluation of diffuse lung disease by conventional chest radiography</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Evaluation of diffuse lung disease by conventional chest radiography</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Evaluation of diffuse lung disease by conventional chest radiography</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Stark, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nestor L Muller, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 05, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The pulmonologist and radiologist commonly recognize a variety of abnormal patterns of diffuse parenchymal lung disease on the conventional chest radiograph. Identification of these patterns, along with recognition of other associated findings, can be extremely useful in guiding the development of a differential diagnosis [<a href="#rid1">1</a>]. The diagnostic approach to diffuse lung disease based on interpretation of the conventional chest radiograph will be discussed here, using examples to illustrate many of the radiographic features.</p><p class="headingAnchor" id="H2"><span class="h1">CRITIQUE OF PATTERN USE</span><span class="headingEndMark"> — </span>The traditional approach to radiographic assessment of diffuse lung disease first involves determining whether the pulmonary parenchymal process is located within the interstitium or the alveolar spaces. However, although radiographic criteria for both types of processes have been established over the years, the correlation is relatively poor between the accuracy of the radiologic localization (to either the airspaces or the interstitium) and the actual pathologic findings. Specific issues include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Nodular patterns can be produced by either interstitial or alveolar disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Interstitial pneumonias usually also involve the alveolar compartment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>So-called alveolar disease regularly involves the interstitium as well. The paradigm of pure alveolar disease is pulmonary alveolar lipoproteinosis, yet high resolution computed tomographic (HRCT) scanning has shown that, even in this entity, the interlobular and intralobular septa are thickened, forming the “crazy paving” pattern on thin-section CT.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Air bronchograms, the ultimate radiographic sign of air space disease, can be detected in a small percentage of cases of histologically pure or predominant interstitial lung disease, such as sarcoidosis, pulmonary lymphoma, and pulmonary calcinosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ground glass opacities are formed by either alveolar or interstitial disease.</p><p></p><p>Because of these limitations, a more descriptive approach has been promulgated by radiologists. This approach takes into account an analysis of predominant opacities, an analysis of lung volumes, distribution of disease, and the presence of associated findings as well as the acuity or chronicity of the disease process [<a href="#rid2">2-4</a>] (<a class="graphic graphic_table graphicRef54536" href="/d/graphic/54536.html" rel="external">table 1</a>). </p><p class="headingAnchor" id="H3"><span class="h1">CLASSIFICATION</span><span class="headingEndMark"> — </span>An attempt to avoid the usage of histologic terminology was made by the International Labor Office (ILO) in graphically describing the radiographic findings of pneumoconioses. The ILO classification system uses standard chest radiographs, graphic rather than anatomic descriptors, and a semiquantitative scheme for profusion of opacities (based on a 12-point scale) [<a href="#rid5">5</a>]. This scheme has an acceptable interobserver variability.</p><p class="bulletIndent1"><span class="glyph">●</span>Small opacities are classified based upon shape (round, irregular, or a combination thereof) and size</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Round (ie, nodular) opacities are characterized as p (up to 1.5 mm) (<a class="graphic graphic_diagnosticimage graphicRef75561" href="/d/graphic/75561.html" rel="external">image 1</a>), q (1.5 to 3 mm) (<a class="graphic graphic_diagnosticimage graphicRef68302" href="/d/graphic/68302.html" rel="external">image 2</a>), and r (3 to 10 mm) (<a class="graphic graphic_diagnosticimage graphicRef67606" href="/d/graphic/67606.html" rel="external">image 3</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Irregular (ie, linear, reticular) opacities are labeled as s (up to 1.5 mm) (<a class="graphic graphic_diagnosticimage graphicRef82072" href="/d/graphic/82072.html" rel="external">image 4</a>), t (1.5 to 3 mm) (<a class="graphic graphic_diagnosticimage graphicRef61246" href="/d/graphic/61246.html" rel="external">image 5</a>), and u (3 to 10 mm)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The profusion of these opacities is assessed, as well as their distribution in the upper, middle, or lower lung zones</p><p></p><p>In practical terms, the predominant small opacity is best identified on the frontal chest radiograph in areas of low profusion and on the lateral chest radiograph in the retrosternal clear space and over the cardiac silhouette.</p><p>This classification, or at least basic elements of it, can also be utilized for description of diffuse lung diseases outside the realm of the pneumoconioses.</p><p class="headingAnchor" id="H4"><span class="h2">Large opacities</span><span class="headingEndMark"> — </span>The ILO classification also makes provision for describing large opacities (<a class="graphic graphic_diagnosticimage graphicRef72316" href="/d/graphic/72316.html" rel="external">image 6</a> and <a class="graphic graphic_diagnosticimage graphicRef52306" href="/d/graphic/52306.html" rel="external">image 7</a>). The application of this principle to pulmonary consolidation avoids pseudo-histologic nomenclature that does not correspond to the actual findings or is misleading, eg, airspace disease, alveolar disease, or “infiltrate.” The terms parenchymal consolidation, parenchymal disease, or parenchymal opacification are more graphic and descriptive, allowing for creation of a differential diagnosis without implying a particular histology.</p><p>Large opacities can be described as:</p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse homogeneous</p><p class="bulletIndent1"><span class="glyph">●</span>Multifocal patchy (<a class="graphic graphic_diagnosticimage graphicRef59037" href="/d/graphic/59037.html" rel="external">image 8</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Lobar without atelectasis</p><p class="bulletIndent1"><span class="glyph">●</span>Lobar with atelectasis</p><p class="bulletIndent1"><span class="glyph">●</span>Perihilar</p><p class="bulletIndent1"><span class="glyph">●</span>Peripheral (<a class="graphic graphic_diagnosticimage graphicRef111654" href="/d/graphic/111654.html" rel="external">image 9</a> and <a class="graphic graphic_diagnosticimage graphicRef116890" href="/d/graphic/116890.html" rel="external">image 10</a>)</p><p></p><p>These six patterns cover the majority of consolidative lung parenchymal abnormalities. These terms should be used rather than the word "infiltrate," which often has an associated diagnostic connotation, ie, suggesting pneumonia [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H5"><span class="h1">BASIC PATTERNS</span><span class="headingEndMark"> — </span>The main radiological patterns often used to describe diffuse lung disease are as follows [<a href="#rid1">1,2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nodular (including micronodular and miliary)</p><p class="bulletIndent1"><span class="glyph">●</span>Reticular (fine or ground glass, medium or irregular, coarse or honeycomb) (<a class="graphic graphic_diagnosticimage graphicRef60208" href="/d/graphic/60208.html" rel="external">image 11</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Linear (interlobular septal or Kerley lines and intralobular septal lines)</p><p class="bulletIndent1"><span class="glyph">●</span>Combined reticular and nodular</p><p class="bulletIndent1"><span class="glyph">●</span>Destructive</p><p class="bulletIndent1"><span class="glyph">●</span>Alveolar</p><p class="bulletIndent1"><span class="glyph">●</span>Bronchial</p><p class="bulletIndent1"><span class="glyph">●</span>Vascular</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Micronodular</span><span class="headingEndMark"> — </span>Micronodules correspond to the p opacities of the International Labor Office (ILO) classification and have a diameter of less than 1.5 mm. They are seen only infrequently and are caused by a small number of diseases:</p><p class="bulletIndent1"><span class="glyph">●</span>Alveolar microlithiasis, a rare disorder characterized by the intraalveolar accumulation of lamellated calcospherites in the absence of abnormal systemic calcium homeostasis (<a class="graphic graphic_diagnosticimage graphicRef79692" href="/d/graphic/79692.html" rel="external">image 12</a> and <a class="graphic graphic_diagnosticimage graphicRef121983" href="/d/graphic/121983.html" rel="external">image 13</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intravenous talc injection (in drug abusers), with subsequent talc granulomatosis also called excipient lung disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Embolization of Ethiodol (after bipedal lymphangiography)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Early stages of pneumoconioses such as silicosis, coal worker's pneumoconiosis, inhalational talcosis (not to be confused with hematogenous talc granulomatosis), and beryllium disease</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Subacinar foci in air space disease, eg, early stages of pulmonary alveolar lipoproteinosis or Pneumocystis jirovecii pneumonia (see  <a class="medical medical_review" href="/d/html/3704.html" rel="external">"Epidemiology, clinical presentation, and diagnosis of Pneumocystis pulmonary infection in patients with HIV"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rare cases of granulomatous disease like disseminated mycobacterial infection, disseminated fungal disease, or sarcoidosis</p><p></p><p class="headingAnchor" id="H7"><span class="h2">Nodular</span><span class="headingEndMark"> — </span>The nodular pattern includes nodules up to 1 cm in diameter (<a class="graphic graphic_diagnosticimage graphicRef50429" href="/d/graphic/50429.html" rel="external">image 14</a>). Causes include:</p><p class="bulletIndent1"><span class="glyph">●</span>Infectious or inflammatory granulomata (eg, miliary tuberculosis, sarcoidosis, fungal diseases, hypersensitivity pneumonitis [extrinsic allergic alveolitis], Langerhans cell histiocytosis [previously eosinophilic granuloma], cytomegalovirus pneumonia, and, occasionally, influenza, parainfluenza, human metapneumovirus, measles, varicella, or respiratory syncytial virus pneumonia) (<a class="graphic graphic_diagnosticimage graphicRef57178" href="/d/graphic/57178.html" rel="external">image 15</a>) [<a href="#rid6">6</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pneumoconioses (eg, silicosis, coal worker's pneumoconiosis, talcosis, and beryllium-induced disease) (<a class="graphic graphic_diagnosticimage graphicRef75722" href="/d/graphic/75722.html" rel="external">image 16</a> and <a class="graphic graphic_diagnosticimage graphicRef116895" href="/d/graphic/116895.html" rel="external">image 17</a> and <a class="graphic graphic_diagnosticimage graphicRef79172" href="/d/graphic/79172.html" rel="external">image 18</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neoplasia (eg, disseminated primary adenocarcinoma of the lung, metastatic carcinoma, and lymphoma) (<a class="graphic graphic_diagnosticimage graphicRef66519" href="/d/graphic/66519.html" rel="external">image 19</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary hemosiderosis</p><p></p><p>Nodular disease becomes visible through a summation effect unless the nodules are larger than 5 mm, their profusion is very low, or the nodules are displayed free of superimposition on HRCT (thin-section CT). Nodular disease can also appear as a combined reticular and nodular pattern on the chest radiograph, a variant of the so called moire effect.</p><p class="headingAnchor" id="H8"><span class="h2">Linear</span><span class="headingEndMark"> — </span>Linear opacities are mostly due to thickened interlobular septa. Kerley, a British radiologist, first described these lines in coal worker's pneumoconiosis.</p><p class="bulletIndent1"><span class="glyph">●</span>Kerley A lines radiate from the hilum into the lung periphery preferentially towards the upper lobes. They represent thickening of the axial pulmonary interstitium. They appear frequently in acute left ventricular failure or in pulmonary edema due to altered capillary permeability (<a class="graphic graphic_diagnosticimage graphicRef63891" href="/d/graphic/63891.html" rel="external">image 20</a> and <a class="graphic graphic_diagnosticimage graphicRef121982" href="/d/graphic/121982.html" rel="external">image 21</a>). These lines have a length of 2 to 4 cm.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Kerley B lines result from thickening of the subpleural interstitium. They are about 1 cm in length, 1 mm in thickness, and have a predilection for the lower lung zones abutting a pleural surface. These lines are particularly well seen in chronic left ventricular failure, mitral valve disease, lymphangitic carcinomatosis, and asbestosis. Kerley B lines can be observed in viral pneumonia, particularly with Hantavirus, coronavirus, and measles pneumonia [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Kerley C lines are due to thickening of the lung parenchymal interstitium and can yield a reticular rather than a linear pattern on chest radiography.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Occasionally, the wall of subpleural emphysematous spaces due to paraseptal emphysema can form linear opacities that resemble Kerley B lines, but are longer and extend more cephalad. Infectious or respiratory bronchiolitis with associated interstitial lung disease (RBILD) can produce linear shadows that do not quite abut the pleura.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thickening of bronchial walls or bronchiectases can result in a linear pattern on chest radiographs, but with a more central, perihilar distribution also dubbed tram lines or tram tracks.</p><p></p><p class="headingAnchor" id="H9"><span class="h2">Reticular</span><span class="headingEndMark"> — </span>A reticular pattern corresponds to the small irregular opacities in the ILO classification (<a class="graphic graphic_diagnosticimage graphicRef82072" href="/d/graphic/82072.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef61246" href="/d/graphic/61246.html" rel="external">image 5</a>). The differential diagnosis is based upon the acuteness or the chronicity of the process.</p><p class="headingAnchor" id="H10"><span class="h3">Acute diseases</span><span class="headingEndMark"> — </span>Acute diseases which produce a reticular pattern include:</p><p class="bulletIndent1"><span class="glyph">●</span>Interstitial pulmonary edema due to left ventricular failure (so-called Kerley C lines)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute viral, chlamydia, or mycoplasma pneumonia</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute pneumonia in collagen vascular disease, particularly systemic lupus erythematosus (<a class="graphic graphic_diagnosticimage graphicRef58248" href="/d/graphic/58248.html" rel="external">image 22</a>) (see  <a class="medical medical_review" href="/d/html/4681.html" rel="external">"Pulmonary manifestations of systemic lupus erythematosus in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute allergic reactions, eg, transfusion reactions (<a class="graphic graphic_diagnosticimage graphicRef63891" href="/d/graphic/63891.html" rel="external">image 20</a>)</p><p></p><p class="headingAnchor" id="H11"><span class="h3">Chronic diseases</span><span class="headingEndMark"> — </span>Chronic reticular changes are generally due to:</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic interstitial pneumonias (primarily idiopathic pulmonary fibrosis [IPF]/usual interstitial pneumonia [UIP], but also nonspecific interstitial pneumonia in its fibrosing variant [fibrosing NSIP], desquamative interstitial pneumonia [DIP], lymphocytic interstitial pneumonia [LIP], and, occasionally, cryptogenic organizing pneumonia [COP]/bronchiolitis obliterans with organizing pneumonia [BOOP]) [<a href="#rid7">7</a>] (<a class="graphic graphic_diagnosticimage graphicRef76204" href="/d/graphic/76204.html" rel="external">image 23</a> and <a class="graphic graphic_diagnosticimage graphicRef55168" href="/d/graphic/55168.html" rel="external">image 24</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Collagen vascular diseases (eg, scleroderma, rheumatoid lung) with UIP or NSIP histology (<a class="graphic graphic_diagnosticimage graphicRef61363" href="/d/graphic/61363.html" rel="external">image 25</a> and <a class="graphic graphic_diagnosticimage graphicRef78807" href="/d/graphic/78807.html" rel="external">image 26</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Asbestosis</p><p class="bulletIndent1"><span class="glyph">●</span>Radiation pneumonitis</p><p class="bulletIndent1"><span class="glyph">●</span>End-stage hypersensitivity pneumonitis (ie, extrinsic allergic alveolitis)</p><p class="bulletIndent1"><span class="glyph">●</span>Drug reactions</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphangitic spread of tumor (<a class="graphic graphic_diagnosticimage graphicRef88743" href="/d/graphic/88743.html" rel="external">image 27</a> and <a class="graphic graphic_diagnosticimage graphicRef88744" href="/d/graphic/88744.html" rel="external">image 28</a>) </p><p class="bulletIndent1"><span class="glyph">●</span>End-stage granulomatous infections</p><p class="bulletIndent1"><span class="glyph">●</span>End-stage Langerhans cell histiocytosis (previously eosinophilic granuloma)</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphangioleiomyomatosis</p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis (<a class="graphic graphic_diagnosticimage graphicRef56653" href="/d/graphic/56653.html" rel="external">image 29</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>LIP</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphoma – bronchovascular form</p><p class="bulletIndent1"><span class="glyph">●</span>Kaposi's sarcoma – bronchovascular form</p><p></p><p>The distribution of chronic reticular changes can also provide clues to the underlying diagnosis. These patterns include:</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic interstitial pneumonias, asbestosis, drug reactions, and collagen vascular disease have a predilection for the periphery of the lung and are basal predominant. Sarcoid, lymphoma, and Kaposi's sarcoma tend to progress from the perihilar lung regions to the periphery. Early stages of Langerhans cell histiocytosis occur preferentially in the upper lung regions.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lymphangioleiomyomatosis, advanced Langerhans cell histiocytosis (previously eosinophilic granuloma), granulomatous infections, and lymphangitic spread of tumor have a diffuse distribution.</p><p></p><p>Reticular and linear changes can mimic combined reticulonodular pathology at the point of intersection of lines. This is called the moiré effect, defined as a visual perception that results from superimposition of a repetitive design and yields a pattern distinctive from its original components.</p><p>Honeycombing is a feature of endstage interstitial lung disease. It represents restructuring of the lung parenchyma, with simplification of the lung architecture and subsequent small cyst formation surrounded by fibrotic tissue. Accompanying bronchiolectasis is regularly present. The small subpleural spaces, which usually measure between 3 and 10 mm in diameter may connect with small airway and some collapse on expiratory imaging. Honeycombs are usually stacked and are not separated by intervening normal lung. Bronchiolectases which can mimic honeycombing are usually separated by interposed lung parenchyma. The expiratory collapse of some of these spaces distinguishes them from the subpleural spaces formed by paraseptal emphysema, which do not decrease in size with expiration. In addition, honeycombs have slightly thicker walls than emphysematous spaces. Honeycombing forms an array of multilayered, stacked spaces, while paraseptal emphysematous spaces are single-layered (ie, single-tiered) [<a href="#rid8">8</a>]. The differentiation of honeycombing, bronchiolectasis and paraseptal emphysema is best achieved with high resolution computed tomography.</p><p>Honeycombing is regularly seen in patients with:</p><p class="bulletIndent1"><span class="glyph">●</span>IPF/UIP</p><p class="bulletIndent1"><span class="glyph">●</span>Fibrotic non-specific interstitial pneumonia (NSIP)</p><p class="bulletIndent1"><span class="glyph">●</span>Langerhans cell histiocytosis (previously eosinophilic granuloma)</p><p class="bulletIndent1"><span class="glyph">●</span>Collagen vascular diseases, eg, rheumatoid ILD or scleroderma lung disease</p><p class="bulletIndent1"><span class="glyph">●</span>Healed necrotizing infections</p><p class="bulletIndent1"><span class="glyph">●</span>Endstage pneumoconiosis</p><p class="bulletIndent1"><span class="glyph">●</span>Endstage hypersensitivity pneumonitis (ie, extrinsic allergic alveolitis)</p><p></p><p class="headingAnchor" id="H12"><span class="h2">Destructive</span><span class="headingEndMark"> — </span>Small lungs, diffuse consolidation, bronchiolectasis and honeycombing, bullae, cysts, coarse linear scarring, retraction of hilar structures cranially, and pulmonary hypertension with cor pulmonale are all part of the spectrum of destructive lung disease. This type of endstage lung disease can be found as a consequence of diffuse alveolar damage or as the final endpoint in interstitial pneumonias and granulomatous processes.</p><p class="headingAnchor" id="H13"><span class="h2">Alveolar</span><span class="headingEndMark"> — </span>Radiologic features of alveolar or air space disease include:</p><p class="bulletIndent1"><span class="glyph">●</span>Airspace (ie, acinar) nodules, 0.6 to 1 cm in diameter (<a class="graphic graphic_diagnosticimage graphicRef70236" href="/d/graphic/70236.html" rel="external">image 30</a> and <a class="graphic graphic_diagnosticimage graphicRef116892" href="/d/graphic/116892.html" rel="external">image 31</a>). These nodules do not represent an acinus in the strict anatomic sense, since they are encompassing peribronchiolar lung tissue.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ground-glass opacification in the early stages of the process (<a class="graphic graphic_diagnosticimage graphicRef61559" href="/d/graphic/61559.html" rel="external">image 32</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Coalescent opacities (<a class="graphic graphic_diagnosticimage graphicRef58394" href="/d/graphic/58394.html" rel="external">image 33</a> and <a class="graphic graphic_diagnosticimage graphicRef116898" href="/d/graphic/116898.html" rel="external">image 34</a> and <a class="graphic graphic_diagnosticimage graphicRef116896" href="/d/graphic/116896.html" rel="external">image 35</a> and <a class="graphic graphic_diagnosticimage graphicRef62269" href="/d/graphic/62269.html" rel="external">image 36</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Consolidation that tends to follow lobar or segmental boundaries (<a class="graphic graphic_diagnosticimage graphicRef81172" href="/d/graphic/81172.html" rel="external">image 37</a> and <a class="graphic graphic_diagnosticimage graphicRef116897" href="/d/graphic/116897.html" rel="external">image 38</a> and <a class="graphic graphic_diagnosticimage graphicRef76321" href="/d/graphic/76321.html" rel="external">image 39</a> and <a class="graphic graphic_diagnosticimage graphicRef116893" href="/d/graphic/116893.html" rel="external">image 40</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Consolidation with a bronchocentric distribution.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Air bronchograms (<a class="graphic graphic_diagnosticimage graphicRef81172" href="/d/graphic/81172.html" rel="external">image 37</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Air alveolograms.</p><p></p><p>As noted above, these radiographic features do not guarantee the exclusive histologic presence of alveolar filling, but they are helpful in attempting to place a disease into a particular radiological category.</p><p class="headingAnchor" id="H14"><span class="h2">Bronchial</span><span class="headingEndMark"> — </span>Diffuse bronchiectasis represents the classic example of a bronchial pattern. On conventional chest radiographs, linear opacities and lucencies are visible, conforming to the course of bronchi (<a class="graphic graphic_diagnosticimage graphicRef55878" href="/d/graphic/55878.html" rel="external">image 41</a> and <a class="graphic graphic_diagnosticimage graphicRef116894" href="/d/graphic/116894.html" rel="external">image 42</a> and <a class="graphic graphic_diagnosticimage graphicRef72062" href="/d/graphic/72062.html" rel="external">image 43</a>). In asthmatics and patients with chronic bronchitis, the wall of thickened bronchi can be seen en face as ring shadows with a wall thickness exceeding 1 mm or in tangent, forming so called tram lines. Mucoid impaction, seen in asthmatics or in patients with allergic bronchopulmonary aspergillosis, produces variable appearances, including abnormalities that are described as V-shaped, Y-shaped, toothpaste shadows, "cluster of grapes" opacities, or "finger in glove" opacities (<a class="graphic graphic_diagnosticimage graphicRef62091" href="/d/graphic/62091.html" rel="external">image 44</a>).</p><p>Cystic spaces are prevalent in saccular or cystic bronchiectasis, with occasional gas-liquid levels. The "dirty lungs" pattern seen in smokers with chronic bronchitis is likely due to peribronchial fibrosis and bronchial wall thickening, with accompanying mild cylindrical bronchiectasis and pulmonary hypertension. Bronchiectases have a central, perihilar predilection as they extend into the more peripheral lung [<a href="#rid9">9</a>].</p><p class="headingAnchor" id="H15"><span class="h2">Vascular</span><span class="headingEndMark"> — </span>Several patterns of pulmonary blood flow can be distinguished on conventional chest radiographs [<a href="#rid10">10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Caudalisation is the normal flow pattern, with basal vessels being two to three times wider than apical vessels.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cephalization occurs with left ventricular failure (<a class="graphic graphic_diagnosticimage graphicRef58231" href="/d/graphic/58231.html" rel="external">image 45</a>), mitral valve stenosis (<a class="graphic graphic_diagnosticimage graphicRef74462" href="/d/graphic/74462.html" rel="external">image 46</a>), basal emphysema (<a class="graphic graphic_diagnosticimage graphicRef65594" href="/d/graphic/65594.html" rel="external">image 47</a>), or in recumbent patients. The upper lobe vessels are more dilated than the basal vessels.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Equalization or balanced flow with hyperemia is seen in hyperkinetic circulation due to left-to-right shunts, hyperthyroidism (<a class="graphic graphic_diagnosticimage graphicRef82599" href="/d/graphic/82599.html" rel="external">image 48</a>), pregnancy, anemia, or after exercise. Equalization implies that the upper and lower lobe pulmonary vessels are similar in size with recruitment of the peripheral pulmonary vessels.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Equalization or balanced flow with oligemia occurs in hypovolemia or right-to-left shunts (eg, tetralogy of Fallot).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Centralization, which reflects dilation of central pulmonary arteries with a concurrently normal or diminished peripheral circulation, is seen in pulmonary hypertension (<a class="graphic graphic_diagnosticimage graphicRef62807" href="/d/graphic/62807.html" rel="external">image 49</a> and <a class="graphic graphic_diagnosticimage graphicRef56714" href="/d/graphic/56714.html" rel="external">image 50</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lateralization of flow to one lung over the other, ie, asymmetric perfusion, is seen with unilateral emphysema or unilateral obstruction of the pulmonary artery. Unilateral dilation of one central pulmonary artery with subtending oligemia, so called Fleischner sign, can indicate massive acute pulmonary embolism. If the right interlobar artery is abruptly cut off due to acute massive pulmonary embolism, it can form the “sausage sign” or Palla sign [<a href="#rid11">11</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Localization of flow or a mosaic pattern of perfusion is seen with patchy emphysema, chronic thromboembolic pulmonary arterial hypertension (CTEPH), bronchiolitis obliterans, or arteriovenous malformations (<a class="graphic graphic_diagnosticimage graphicRef54915 graphicRef66676" href="/d/graphic/54915.html" rel="external">image 51A-B</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Collateralization is seen with bronchial or other systemic arterial supply to the lungs, resulting in a lattice-like pattern of vessels. It is seen with severe tetralogy of Fallot or in proximal interruption of the pulmonary artery (<a class="graphic graphic_diagnosticimage graphicRef66743" href="/d/graphic/66743.html" rel="external">image 52</a> and <a class="graphic graphic_diagnosticimage graphicRef70102" href="/d/graphic/70102.html" rel="external">image 53</a>).</p><p></p><p class="headingAnchor" id="H16"><span class="h1">LUNG VOLUMES</span><span class="headingEndMark"> — </span>A frequent feature of chronic diffuse infiltrative lung disease is loss of lung volume. Occasionally, low lung volumes can represent the first manifestation of such a process.</p><p>However, some of the chronic diffuse infiltrative lung diseases are associated with normal or large lung volumes, often as a result of airflow obstruction or cystic changes that accompany the disease. Examples of chronic diffuse infiltrative lung disease that can be associated with normal or large lung volumes include:</p><p class="bulletIndent1"><span class="glyph">●</span>Langerhans cell histiocytosis (previously eosinophilic granuloma).</p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis (preserved lung volumes) (<a class="graphic graphic_diagnosticimage graphicRef56653" href="/d/graphic/56653.html" rel="external">image 29</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphangioleiomyomatosis (hyperexpanded lungs).</p><p class="bulletIndent1"><span class="glyph">●</span>Cystic fibrosis (hyperexpanded lungs). It should be noted that cystic fibrosis is primarily a form of airways disease rather than infiltrative lung disease.</p><p class="bulletIndent1"><span class="glyph">●</span>Combined pulmonary fibrosis and emphysema (CPFE).</p><p></p><p class="headingAnchor" id="H17"><span class="h1">DISEASE DISTRIBUTION</span><span class="headingEndMark"> — </span>The anatomic distribution of lung disease can greatly facilitate the approach to differential diagnosis.</p><p>Upper zone lung disease is found preferentially in:</p><p class="bulletIndent1"><span class="glyph">●</span>Tuberculosis</p><p class="bulletIndent1"><span class="glyph">●</span>Fungal disease</p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis (<a class="graphic graphic_diagnosticimage graphicRef80390" href="/d/graphic/80390.html" rel="external">image 54</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Pneumoconiosis (with the notable exception of asbestosis) (<a class="graphic graphic_diagnosticimage graphicRef79172" href="/d/graphic/79172.html" rel="external">image 18</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Langerhans cell histiocytosis (previously eosinophilic granuloma)</p><p class="bulletIndent1"><span class="glyph">●</span>Ankylosing spondylitis</p><p class="bulletIndent1"><span class="glyph">●</span>Cystic fibrosis (<a class="graphic graphic_diagnosticimage graphicRef55878" href="/d/graphic/55878.html" rel="external">image 41</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Cystic Pneumocystis jirovecii pneumonia</p><p class="bulletIndent1"><span class="glyph">●</span>Radiation fibrosis</p><p class="bulletIndent1"><span class="glyph">●</span>Endstage hypersensitivity pneumonitis (ie, extrinsic allergic alveolitis)</p><p></p><p>Basal lung disease is found in a different group of diseases:</p><p class="bulletIndent1"><span class="glyph">●</span>Bronchiectasis</p><p class="bulletIndent1"><span class="glyph">●</span>Aspiration pneumonia</p><p class="bulletIndent1"><span class="glyph">●</span>Desquamative interstitial pneumonia (DIP)</p><p class="bulletIndent1"><span class="glyph">●</span>Nonspecific interstitial pneumonia and fibrosis</p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic interstitial pneumonia (IPF)/usual interstitial pneumonia (UIP)</p><p class="bulletIndent1"><span class="glyph">●</span>Drug reactions</p><p class="bulletIndent1"><span class="glyph">●</span>Asbestosis</p><p class="bulletIndent1"><span class="glyph">●</span>Scleroderma</p><p class="bulletIndent1"><span class="glyph">●</span>Rheumatoid arthritis</p><p class="bulletIndent1"><span class="glyph">●</span>Vaping-induced lung disease (EVALI) (<a class="graphic graphic_diagnosticimage graphicRef132334" href="/d/graphic/132334.html" rel="external">image 55</a>) [<a href="#rid12">12</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>COVID-19 pneumonia (<a class="graphic graphic_diagnosticimage graphicRef132335" href="/d/graphic/132335.html" rel="external">image 56</a>)</p><p></p><p>Central, perihilar lung disease occurs in <strong>chronic</strong> diseases including:</p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphoma</p><p class="bulletIndent1"><span class="glyph">●</span>Kaposi's sarcoma</p><p class="bulletIndent1"><span class="glyph">●</span>Bronchiectases</p><p></p><p>Central, perihilar lung disease also occurs <strong>acutely</strong>. As examples: </p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary edema (appears as perihilar, batwing, or butterfly pattern)</p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary hemorrhage</p><p class="bulletIndent1"><span class="glyph">●</span>Bacterial pneumonia</p><p></p><p>Peripheral lung disease is found in the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Cryptogenic organizing pneumonia (COP; previously also called bronchiolitis obliterans organizing pneumonia [BOOP] as well as IPF/UIP and DIP)</p><p class="bulletIndent1"><span class="glyph">●</span>Asbestosis</p><p class="bulletIndent1"><span class="glyph">●</span>Coronavirus disease 2019 (COVID-19) pneumonia (<a class="graphic graphic_diagnosticimage graphicRef132335" href="/d/graphic/132335.html" rel="external">image 56</a>). Multifocal bilateral peripheral opacities with rounded morphology [<a href="#rid13">13,14</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Eosinophilic lung disease with the photographic negative of pulmonary edema pattern [<a href="#rid15">15</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Graft-versus-host disease</p><p class="bulletIndent1"><span class="glyph">●</span>Rare cases of pseudoalveolar sarcoidosis</p><p class="bulletIndent1"><span class="glyph">●</span>Rare cases of mucinous adenocarcinoma (bronchioloalveolar carcinoma)</p><p></p><p>These patterns of distribution are often quite useful, but any infiltrative lung process in advanced stages can involve both lungs diffusely [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H18"><span class="h1">ASSOCIATED FINDINGS</span><span class="headingEndMark"> — </span>Associated radiographic findings related to the pleura, hilar regions, mediastinum, bronchi, cardiac structures, and pulmonary vasculature can provide diagnostic clues in the setting of diffuse parenchymal lung disease.</p><p class="headingAnchor" id="H19"><span class="h2">Pleural disease</span><span class="headingEndMark"> — </span>Pleural disease occasionally accompanies diffuse lung disease and can help narrow the differential diagnosis.</p><p class="bulletIndent1"><span class="glyph">●</span>Pneumothorax is classically described in Langerhans cell histiocytosis (previously eosinophilic granuloma) of the lung, but it is also a relatively common complication of advanced interstitial lung disease of any etiology. The highest frequency of pneumothoraces is described in lymphangioleiomyomatosis. (See  <a class="medical medical_review" href="/d/html/4335.html" rel="external">"Sporadic lymphangioleiomyomatosis: Epidemiology and pathogenesis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pleural effusions are seen in patients with metastatic malignancy (including lymphangitic carcinomatosis), collagen vascular diseases (especially systemic lupus erythematosus and rheumatoid arthritis), lymphangioleiomyomatosis with chylothorax (<a class="graphic graphic_diagnosticimage graphicRef56652" href="/d/graphic/56652.html" rel="external">image 57</a>), and, occasionally, as a complication of asbestos exposure. The entity of benign asbestos pleural effusion has no relationship to pleural plaques and occurs much earlier following exposure to the asbestos fibers.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pleural plaques are characteristically seen in longstanding asbestos exposure. They accompany the lung fibrosis of asbestosis in 30 to 50 percent of cases.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Focal pleural thickening is, on occasion, seen as a sequela of amyloidosis involving the lungs.</p><p></p><p class="headingAnchor" id="H20"><span class="h2">Lymph node enlargement</span><span class="headingEndMark"> — </span>Diffuse lung disease can be accompanied by enlarged intrathoracic lymph nodes, visible either on chest radiographs or on CT scans. The following diseases can be associated with diffuse pulmonary involvement and enlarged intrathoracic lymph nodes:</p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis (<a class="graphic graphic_diagnosticimage graphicRef78632" href="/d/graphic/78632.html" rel="external">image 58</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphoma</p><p class="bulletIndent1"><span class="glyph">●</span>Tuberculosis</p><p class="bulletIndent1"><span class="glyph">●</span>Fungal diseases</p><p class="bulletIndent1"><span class="glyph">●</span>Pneumoconioses (especially silicosis, coal-worker’s pneumoconiosis, and beryllium disease)</p><p class="bulletIndent1"><span class="glyph">●</span>Bronchogenic carcinoma</p><p class="bulletIndent1"><span class="glyph">●</span>Metastatic tumors other than bronchogenic carcinoma</p><p></p><p class="headingAnchor" id="H21"><span class="h2">Cor pulmonale</span><span class="headingEndMark"> — </span>Right ventricular hypertrophy and dilation subsequent to pulmonary hypertension is found in a high percentage of patients with end-stage diffuse lung disease. Obliteration of small peripheral pulmonary artery branches in combination with hypoxic vasoconstriction leads to pulmonary hypertension. This is classified as pulmonary hypertension, group 3 in the WHO classification of pulmonary hypertension [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/d/html/8262.html" rel="external">"Pulmonary hypertension due to lung disease and/or hypoxemia (group 3 pulmonary hypertension): Epidemiology, pathogenesis, and diagnostic evaluation in adults"</a>.)</p><p class="headingAnchor" id="H22"><span class="h1">NORMAL RADIOGRAPHS IN SYMPTOMATIC PATIENTS</span><span class="headingEndMark"> — </span>In about 10 percent of patients with biopsy-proven diffuse interstitial lung disease, the chest radiograph is initially normal, even though the patient is dyspneic, may have decreased exercise tolerance, or has a decreased diffusion capacity of carbon monoxide (DLCO). The best examples are:</p><p class="bulletIndent1"><span class="glyph">●</span>Desquamative interstitial pneumonia</p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis</p><p class="bulletIndent1"><span class="glyph">●</span>Hypersensitivity pneumonitis (ie, extrinsic allergic alveolitis)</p><p class="bulletIndent1"><span class="glyph">●</span>Pneumocystis pneumonia in HIV-infected patients</p><p></p><p>In such situations, high resolution CT scanning (thin-section CT) can add information and detect subtle ground-glass opacities not suspected on conventional radiographs. (See  <a class="medical medical_review" href="/d/html/6988.html" rel="external">"High resolution computed tomography of the lungs"</a> and  <a class="medical medical_review" href="/d/html/4358.html" rel="external">"Approach to the adult with interstitial lung disease: Diagnostic testing"</a>.)</p><p class="headingAnchor" id="H23"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pattern recognition</strong> - Pattern recognition on a conventional chest radiograph is an important first step in the evaluation of patients with diffuse lung disease, although a multitude of diseases can produce the same pattern. (See <a class="local">'Critique of pattern use'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification</strong> - A graphic description is preferable to use of histologic terminology. (See <a class="local">'Classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Basic patterns</strong> - The main radiological patterns used to describe diffuse lung disease are as follows: Nodular (including micronodular and miliary), reticular (fine or ground glass, medium or irregular, and coarse with or without honeycombing), linear (interlobular septal or Kerley lines), combined reticular and nodular, destructive, alveolar, bronchial, and vascular. (See <a class="local">'Basic patterns'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Volume, distribution other findings</strong> - Additional aspects of lung disease that may be characterized by conventional chest radiography are the lung volumes, disease distribution, and associated findings. (See <a class="local">'Lung volumes'</a> above and <a class="local">'Disease distribution'</a> above and <a class="local">'Associated findings'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Computed tomography</strong> - HRCT (thin-section CT) is a very helpful tool to supplement the information from conventional chest radiography. It can refine the differential diagnostic considerations and has improved sensitivity and specificity over conventional chest radiography, particularly in complex cases. In some situations, such as in idiopathic pulmonary fibrosis, HRCT can be definitive and obviate the need for a biopsy. However, in selected cases, biopsy may be needed for a definitive diagnosis, particularly if treatment depends on a specific diagnosis. (See  <a class="medical medical_review" href="/d/html/6988.html" rel="external">"High resolution computed tomography of the lungs"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Felson B. A new look at pattern recognition of diffuse pulmonary disease. AJR Am J Roentgenol 1979; 133:183.</a></li><li class="breakAll">Genereux GP. Radiologic assessment of diffuse lung disease. In: Radiology, Diagnosis, Imaging, Intervention, Taveras, Ferrucci (Eds), JP Lippincott, Philadelphia 1992. Vol 1, p.1-18.</li><li><a class="nounderline abstract_t">McLoud TC, Carrington CB, Gaensler EA. Diffuse infiltrative lung disease: a new scheme for description. Radiology 1983; 149:353.</a></li><li class="breakAll">McLoud TC. Chronic infiltrative lung disorders. In: Radiology, Diagnosis, Imaging, Intervention, Taveras, Ferrucci (Eds), JP Lippincott, Philadelphia 1992. Vol 1, p.1-17.</li><li><a class="nounderline abstract_t">Russell, A (Ed). International Labour Office: Guidelines for the Use of ILO International Classification of Radiographs of Pneumoconioses. Revised Edition 1980. Medical Radiography and Photography 1981; 1:2.</a></li><li><a class="nounderline abstract_t">Franquet T. Imaging of pulmonary viral pneumonia. Radiology 2011; 260:18.</a></li><li><a class="nounderline abstract_t">Mueller-Mang C, Grosse C, Schmid K, et al. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics 2007; 27:595.</a></li><li><a class="nounderline abstract_t">Arakawa H, Honma K. Honeycomb lung: history and current concepts. AJR Am J Roentgenol 2011; 196:773.</a></li><li><a class="nounderline abstract_t">Milliron B, Henry TS, Veeraraghavan S, Little BP. Bronchiectasis: Mechanisms and Imaging Clues of Associated Common and Uncommon Diseases. Radiographics 2015; 35:1011.</a></li><li><a class="nounderline abstract_t">Ravin CE. Pulmonary vascularity: radiographic considerations. J Thorac Imaging 1988; 3:1.</a></li><li><a class="nounderline abstract_t">Sista AK, Kuo WT, Schiebler M, Madoff DC. Stratification, Imaging, and Management of Acute Massive and Submassive Pulmonary Embolism. Radiology 2017; 284:5.</a></li><li><a class="nounderline abstract_t">Kligerman S, Raptis C, Larsen B, et al. Radiologic, Pathologic, Clinical, and Physiologic Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): Evolving Knowledge and Remaining Questions. Radiology 2020; 294:491.</a></li><li><a class="nounderline abstract_t">Litmanovich DE, Chung M, Kirkbride RR, et al. Review of Chest Radiograph Findings of COVID-19 Pneumonia and Suggested Reporting Language. J Thorac Imaging 2020; 35:354.</a></li><li><a class="nounderline abstract_t">Dueck NP, Epstein S, Franquet T, et al. Atypical Pneumonia: Definition, Causes, and Imaging Features. Radiographics 2021; 41:720.</a></li><li><a class="nounderline abstract_t">Gaensler EA, Carrington CB. Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema. AJR Am J Roentgenol 1977; 128:1.</a></li><li><a class="nounderline abstract_t">Müller NL, Coiby TV. Idiopathic interstitial pneumonias: high-resolution CT and histologic findings. Radiographics 1997; 17:1016.</a></li><li><a class="nounderline abstract_t">Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62:D34.</a></li></ol></div><div id="topicVersionRevision">Topic 6979 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/110078" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A new look at pattern recognition of diffuse pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/110078" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : A new look at pattern recognition of diffuse pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6622676" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Diffuse infiltrative lung disease: a new scheme for description.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6622676" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Diffuse infiltrative lung disease: a new scheme for description.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Revised Edition 1980</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21697307" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Imaging of pulmonary viral pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17495281" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : What every radiologist should know about idiopathic interstitial pneumonias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21427324" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Honeycomb lung: history and current concepts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26024063" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Bronchiectasis: Mechanisms and Imaging Clues of Associated Common and Uncommon Diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3336060" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pulmonary vascularity: radiographic considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28628412" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Stratification, Imaging, and Management of Acute Massive and Submassive Pulmonary Embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31990264" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Radiologic, Pathologic, Clinical, and Physiologic Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI): Evolving Knowledge and Remaining Questions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32520846" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Review of Chest Radiograph Findings of COVID-19 Pneumonia and Suggested Reporting Language.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33835878" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Atypical Pneumonia: Definition, Causes, and Imaging Features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/401562" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9225401" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Idiopathic interstitial pneumonias: high-resolution CT and histologic findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24355639" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Updated clinical classification of pulmonary hypertension.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
